EA201000141A1 - Новые триазены для лечения рака - Google Patents

Новые триазены для лечения рака

Info

Publication number
EA201000141A1
EA201000141A1 EA201000141A EA201000141A EA201000141A1 EA 201000141 A1 EA201000141 A1 EA 201000141A1 EA 201000141 A EA201000141 A EA 201000141A EA 201000141 A EA201000141 A EA 201000141A EA 201000141 A1 EA201000141 A1 EA 201000141A1
Authority
EA
Eurasian Patent Office
Prior art keywords
triazenes
new
cancer treatment
treatment
differ
Prior art date
Application number
EA201000141A
Other languages
English (en)
Inventor
Рудольф Райтер
Йохен Кальбе
Хайнц Фёрстер
Original Assignee
Трин Фарма Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Трин Фарма Гмбх filed Critical Трин Фарма Гмбх
Publication of EA201000141A1 publication Critical patent/EA201000141A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C245/00—Compounds containing chains of at least two nitrogen atoms with at least one nitrogen-to-nitrogen multiple bond
    • C07C245/22—Compounds containing chains of at least two nitrogen atoms with at least one nitrogen-to-nitrogen multiple bond containing chains of three or more nitrogen atoms with one or more nitrogen-to-nitrogen double bonds
    • C07C245/24—Chains of only three nitrogen atoms, e.g. diazoamines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C309/13—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
    • C07C309/14—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton containing amino groups bound to the carbon skeleton
    • C07C309/15—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton containing amino groups bound to the carbon skeleton the nitrogen atom of at least one of the amino groups being part of any of the groups, X being a hetero atom, Y being any atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Настоящее изобретение относится к новым триазенам, способу их получения, фармацевтическим композициям, включающим такие соединения, и к их применению при лечении онкозаболеваний у людей. Новые триазены отличаются по сравнению с известными триазенами улучшенной активностью, причем в то же время имеют уменьшенную токсичность, иначе говоря более слабое побочное действие.
EA201000141A 2007-07-04 2008-07-03 Новые триазены для лечения рака EA201000141A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07111716 2007-07-04
PCT/EP2008/058600 WO2009004060A1 (de) 2007-07-04 2008-07-03 Neue triazenverbindungen zur behandlung von krebs

Publications (1)

Publication Number Publication Date
EA201000141A1 true EA201000141A1 (ru) 2010-06-30

Family

ID=38606533

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201000141A EA201000141A1 (ru) 2007-07-04 2008-07-03 Новые триазены для лечения рака

Country Status (13)

Country Link
US (2) US8034797B2 (ru)
EP (1) EP2167459A1 (ru)
JP (1) JP2010531855A (ru)
KR (1) KR20100031620A (ru)
CN (2) CN102424657A (ru)
AU (1) AU2008270269B2 (ru)
BR (2) BRPI0814614A2 (ru)
CA (1) CA2691178A1 (ru)
EA (1) EA201000141A1 (ru)
MX (1) MX2010000223A (ru)
NZ (1) NZ582346A (ru)
TW (1) TW200908986A (ru)
WO (1) WO2009004060A1 (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2686298B1 (de) * 2011-03-16 2018-05-09 Creative Therapeutics GmbH Substituierte diphenylderivate
WO2012130850A1 (de) 2011-03-31 2012-10-04 Bayer Pharma Aktiengesellschaft Gewebetargeting mit onkoziden verbrückten diphenylderivaten zur selektiven behandlung von sexualorgantumoren
EP2557075A1 (de) 2011-08-09 2013-02-13 Trin Therapeutics GmbH Neue Triazenverbindungen zur Behandlung von Krebs
WO2013041204A1 (de) 2011-09-23 2013-03-28 2LUTION GmbH Neue isocyanat- und isothiocyanat-verbindungen zur behandlung von krebs
CN105566153B (zh) * 2014-10-14 2019-05-31 中国医学科学院药物研究所 偶氮苯衍生物及其制法和药物组合物与用途
CN109776526A (zh) * 2019-01-23 2019-05-21 西南医科大学 稠环三唑-(磺酰基)三氮烯类衍生物及其合成方法和用途
DE102020125641A1 (de) 2020-09-25 2022-03-31 Creative Therapeutics Gmbh Wirkstoffe und Arzneimittel für die Therapie von Viruserkrankungen, insbesondere Corona-Infektionen, insbesondere COVID-19

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1793115A1 (de) * 1968-08-03 1972-02-03 Bayer Ag Neue Triazenderivate
BE789138A (fr) * 1971-09-24 1973-03-22 Bayer Ag Nouveaux derives triazeniques, leur procede de preparation et medicament les contenant
DE10324496A1 (de) * 2003-05-30 2004-12-16 Bayer Healthcare Ag Targetorientierte Chemotherapie von Tumoren der Sexualorgane

Also Published As

Publication number Publication date
US8426390B2 (en) 2013-04-23
JP2010531855A (ja) 2010-09-30
EP2167459A1 (de) 2010-03-31
BRPI0823332A2 (pt) 2013-07-30
AU2008270269A1 (en) 2009-01-08
NZ582346A (en) 2012-04-27
AU2008270269B2 (en) 2013-04-04
KR20100031620A (ko) 2010-03-23
MX2010000223A (es) 2010-04-30
WO2009004060A1 (de) 2009-01-08
CA2691178A1 (en) 2009-01-08
TW200908986A (en) 2009-03-01
US20100234327A1 (en) 2010-09-16
AU2008270269A2 (en) 2012-04-12
CN102424657A (zh) 2012-04-25
BRPI0814614A2 (pt) 2011-11-29
US8034797B2 (en) 2011-10-11
CN101796020A (zh) 2010-08-04
US20120028927A1 (en) 2012-02-02

Similar Documents

Publication Publication Date Title
EA201300242A1 (ru) Фармацевтические композиции, содержащие замещенные ациланилиды
EA201100136A1 (ru) 2,4'-бипиридинилы в качестве ингибиторов протеинкиназы d, применимые для лечения сердечной недостаточности и рака
EA201190217A1 (ru) Замещенные 2-ацетамидо-5-арил-1,2,4-триазолоны и их применение
AU2012253757A8 (en) Partially saturated tricyclic compounds and methods of making and using same
EA201001639A1 (ru) Композиции и способы их получения и применения
EA201290919A1 (ru) Индазольные соединения и их применение
MX2009006704A (es) Derivados de amina triciclicos como inhibidores de proteina de tirosina cinasa.
UA107783C2 (en) Isoindoline compounds for use in treating cancer
EA200901133A1 (ru) Производные дианилинопиримидина как ингибиторы киназы wee1, фармацевтическая композиция и применение
EA200901138A1 (ru) Производные дианилинопиримидина как ингибиторы киназы wee1, фармацевтическая композиция и применение
MY155649A (en) Pyridyloxyindoles inhibitors of vegf-r2 and use thereof for treatment of disease
WO2008148074A3 (en) Inhibitors of mtor and methods of treatment using same
MX343135B (es) Compuestos de tipo fumagilol y métodos de realización y uso de los mismos.
EA201101650A1 (ru) Новые производные пиримидина и их применение в лечении злокачественных новообразований и последующих заболеваний
BRPI0915084B8 (pt) composto, e, composição farmacêutica
MX339201B (es) Compuestos de sulfonamida y métodos para elaborarlos y usarlos.
EA201100032A1 (ru) Соединения пиридина
EA200971107A1 (ru) Катехоламиновые производные, полезные для лечения болезни паркинсона
EA201200473A1 (ru) Замещенные (гетероарилметил)тиогидантоины
EA200700601A1 (ru) Производные фениламинопиримидина как ингибиторы bcr-abl
EA201170531A1 (ru) Соединения на основе пиридина и пиримидина в качестве ингибиторов сигнального пути wnt для лечения рака
CO6781549A2 (es) Uso de ligandos sigma en dolor por cáncer de huesos
EA200900044A1 (ru) Замещенные производные 1,3-дифенилпропана, получение и их применение
EA201200323A1 (ru) Соединения и композиции, как ингибиторы протеинкиназы
EA201000141A1 (ru) Новые триазены для лечения рака